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ABSTRACT
Since the introduction of osseointegrated implant treatment, odontology, and in particular the area of prosthodontic 
replacement of lost teeth, has evolved in an unimaginable way, to the extent that the age-old idea of  “restitutio ad in-
tegrum” has almost become possible. 
Implant treatment has a high success rate that has been rated as high as 95 to 99%, according to different casuists, but 
there is another group of cases in which implants fail, and in fact it is hard to know the causes of such failures. 
The microbiological component plays an important role in encouraging and facilitating implant infection during implant 
placement, and also later when the implant is in function in the mouth, which is a septic medium.
In this paper we will study infections in implantology, classified according to the treatment phase: Infection prior to the 
implant; Peri-surgical infection; Severe post-surgical infection; Peri-implant disease.
Key words: Infection, antibiotics, dental implants, peri-implantitis.
RESUMEN
Desde la introducción de los tratamientos con implantes osteointegrados, la evolución de la Odontología y en especial 
la de la parte encargada de la reposición prostodóncica de los dientes perdidos ha sufrido una inimaginable evolución, 
hasta límites tales que el viejo concepto de “restitutio ad integrum” se ha hecho casi posible.
Los tratamientos con implantes tienen un importante porcentaje de éxitos que se ha llegado a cifrar entre un 95 y 99%, 
según diferentes casuísticas, pero hay otro número de casos en los que el fracaso es una realidad, y es difícil incluso saber 
cuáles son las causa de ello.
Al realizarse tanto la inserción de los implantes, como el desarrollo de su función ulterior en un medio séptico tal y como 
es la cavidad bucal, el componente microbiológico juega un importante papel, al favorecer y facilitar las infecciones 
implantarias.
Estudiaremos en este trabajo las infecciones en Implantología, referidas a cuatro etapas del tratamiento: Infecciones previas 
del área implantaria; Infecciones periquirúrgicas; Infecciones postquirúrgicas graves; Enfermedad periimplantaria. 
Palabras clave: Infecciones, antibióticos, implantes dentales, periimplantitis.
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INTRODUCTION
Causes of implant failure
Many causes have been studied on the subject of implant 
failures. Since Bert’s publication (1) to the present-day it is 
clear that implant failure can occur at any time during treat-
ment and subsequently when the implant is in function. 
Implant placement is contraindicated in many cases, and 
almost all authors (2) agree about these cases, because the 
failure rate increases sharply, sometimes jeopardising oral 
health and even the patient’s general state of health. 
Apart from these cases, if  there is no contraindication for 
undergoing the treatment, studies of implant failure reveal 
two main causes of failure: infection and occlusal overload 
(3). The first is associated with the phase prior to placing 
the implant in situ, in direct relation with surgery, and 
the second is associated with implant function following 
prosthodontic rehabilitation. The latter also involves an 
infectious component that is encouraged by microfractures 
in the bone and the appearance of peri-implant pockets, 
with a clear infectious component.
The study conducted by Tonetti’s group (4) is of particular 
note amongst the large number in the literature, because 
it provides a very up-to-date description of predisposing 
factors in implant failure, and attributes greatest prevalence 
to periodontal disease, smoking, and poor oral hygiene, 
which are also related to predisposing factors in Periodontal 
Disease, and determine an aggressive situation from a mi-
crobiological point of view, thus favouring infection. 
When studying the causes of  failure, we will follow the 
classification below, as proposed by Quirynen (5):





This refers to two fundamental conditions: an active septic 
source (regardless of whether or not it is related to root 
remains), and previous periodontal disease.
Active septic site
The presence of an active septic site has traditionally been 
considered as a contraindication for implant placement 
because of the possibility of septic embolism that can cause 
immediate or late post-surgical infection (osteomyelitis, peri-
implant abscess, etc.) and also because of the presence of 
epithelial remains that may jeopardise osseointegration.
Therefore, all authors agree that before performing an im-
plant placement, the affected zone must be carefully derided 
and the area must be completely decontaminated (6, 7, 8).
In view of the importance of cleaning, aiming for a sterile 
implant zone, in the last few years laser use has become more 
common. It has been demonstrated that the use of Er:Yag 
or Diode lasers can be effective in the decontamination of 
infected areas (9).
Periodontal disease
Implant treatments in patients suffering periodontal disease 
has been the subject of many studies. From a microbiologi-
cal point of view, the first studies (10) already reported that 
implants in patients with periodontal disease in remaining 
teeth have a more pathogenic microbiota than completely 
edentulous patients.
A series of important conclusions can be drawn by com-
paring the microbiology of  implants and teeth (11): a) 
microbiological findings in healthy implants are similar 
to those of  healthy teeth; b) microbiological findings in 
infected implants are similar to those of teeth with PD; c) 
subjects at risk of PD are also at risk of peri-implantitis; 
d) periodontal diseased teeth can contaminate implants in 
the same mouth.
Studies by Ellegard (12) and Nevins and Langer (13), 
demonstrated that patients with a history of periodontal 
disease and advanced bone loss can have successful implant 
treatment. Likewise, patients with a high risk of periodontal 
disease can be successfully treated with osseointegrated 
implants. However, Lang’s group (14) noted that patients 
who had implants for teeth lost because of periodontitis 
had lower rates of survival and greater complications than 
those who had lost teeth from other causes. 
Finally, the EAO implantology work group consensus report 
(15) concluded that patients with PD had an implant success 
rate of 91 –92% and patients without PD had a success rate 
of 97%. However, the incidence of peri-implantitis and mar-
ginal bone loss increases significantly in patients with PD. 
In any case, it appears that there is a clear relationship bet-
ween PD history and implant evolution in these patients, 
in such a way that longitudinal bone loss around implants 
is related to a history of periodontal support loss. Subjects 
at risk of periodontitis may have a greater implant failure 
rate than those who are not (16).
Special considerations regarding implant treatment in 
periodontal patients
There are three fundamental factors to consider in implant 
treatment in patients with periodontal disease:
1. Progressive reabsorption in edentulous maxillas has a 
direct relation with the implant prognosis and the height 
of remaining bone.  
There are many articles in the literature that describe a clear 
relation between a long implant length and longevity of im-
plant survival.  The 5-year implant failure rate is 10.86% in 
implants that measure 10 mm or less (17), and at the other 
end of the scale, there is a 96.4% success rate in implants that 
measure up to 16 mm (18). There does not appear to be any 
relation between implant survival and diameter (18).
2. Approach to teeth with a poor prognosis. 
One classical study that was conducted in 1978 by Hirs-
chfield and Wasserman (19), reported on 600 patients with 
periodontal disease who were treated and followed-up over 
a 5 to 15 year period. It was observed that patients who did 
not receive regular treatment for their PD lost up to 31% of 
their teeth, while those who did receive treatment lost 7% 
of their teeth. The conclusion seems clear: if  the future of 
a tooth is unclear, extraction is the best solution.
3. Need for prior treatment of  underlying Periodontal 
Disease
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In 1994, Lang presented a review (20) of the results of im-
plant treatment in patients with PD. From these findings, 
he made two recommendations: to treat PD before implant 
placement, and maintain less deep pockets in patients who 
are implant candidates, increasing surgical periodontal 
treatment if  necessary in order to reduce the pockets. He 
also advised extreme care in smokers and patients at high 
risk of PD. 
Furthermore, the SEPA Periodontal manual (21), states that 
teeth with severe periodontal disease should not be used as 
pillars but should be extracted. It also states that a healthy 
periodontal condition is required before starting restorative 
treatment because a mouth in a poor condition will bring 
complications when restorative treatment is commenced. 
Therefore, before starting implant treatment, any underlying 
periodontal disease must be treated. 
 
PERI-SURGICAL INFECTION
Intraoral surgery has traditionally been classified as clean-
contaminated surgery or contaminated surgery, depending 
when the intervention takes place (22). Implant placement 
surgery is a case of clean-contaminated surgery because the 
surgical field may be contaminated through many causes and 
germs can easily penetrate the operating field. However, the 
excellent vascularisation of the zone and absence of previous 
infection usually prevent infectious processes from occurring 
during these interventions.
Brånemark (23) stated that there are many sources of con-
tamination in surgery and almost all are derived from the 
instrumentation itself  (air, aspiration, instruments them-
selves, etc.) and from the presence of saliva in the surgical 
field, and its relation with face and lips. 
Many different techniques have been used to avoid this 
situation, such as reducing saliva secretions with atropine 
(24), double aspiration to avoid salivary contamination of 
surgery, and the use of chlorhexidine washes that conside-
rably reduce the number of germs present in the mouth (5). 
It has also been suggested that germs from the nose may 
also be significant in surgical field contamination (25) and 
therefore surgical isolation and a clean field play a vital role 
in preventing infection during implant placement.
Clinical manifestations of the infections caused by peri-ope-
rative contamination are usually in the form of peri-implant 
abscesses, characterised by peri-apical radiolucency on X-
ray, often leading to fistulas (5, 26).
SEVERE POSTOPERATIVE INFECTION
Infectious complications of implant surgery can be signifi-
cant. The virulence of the germs involved can cause all sorts 
of infections that can even become life threatening. 
In practice, a full range of oral and maxillofacial infectious 
processes can be found, and treatment of such infection in-
cludes explantation of the implant and appropriate surgical 
treatment, as well as full antibiotic cover. 
One infectious process of particular importance is infection 
derived from bone graft surgery associated with implant 
placement. This occurs either simultaneously or prior to 
the intervention and its importance lies in the fact that in 
addition to the infectious process, there may be repercus-
sions at other levels (immunological reactions, reactions to 
a foreign body, etc.). 
The Gottlow Nyman principles, established over 20 years 
ago, should always be followed in bone regeneration (27):
1. When preparing the area to be regenerated: maintain good 
graft vascularisation, in order to attain sufficient nutrition 
that will prevent early necrosis, at the same time as facilita-
ting the regenerative and wound-healing process. 
Prevent surrounding tissues from collapsing in order to 
maintain space for regeneration. This can be achieved by 
different means: self-maintenance using graft morphology, 
use of a titanium mesh, block grafts...
Ensure that the flap completely covers the graft, using sliding 
plasty or periosteal discharges. In the event of dehiscence, 
use topical antiseptics to avoid colonisation of the exposed 
zone.  
2 Tissue exclusion 
Dahlin’s principles on guided tissue regeneration (28) are of 
full application because it is essential to use membranes or 
other barrier methods to prevent soft tissue infiltration of 
the graft. This is because soft tissues grow much more quic-
kly and this would lead to repair rather than regeneration, 
and proposed objectives would not be attained.
3. The technique used to incorporate regeneration materials 
is very well known and has been discussed by many authors 
(29, 30), but we believe that it is important to mention 
several basic principles: a) immobility of  graft material; 
b) continuous maintenance of the sterile chain; c) ensure 
vascularisation; d) safety and biocompatibility of  graft 
material.
Likewise, a series of basic post-operative principles should 
be followed to ensure that the graft progresses well (31): a) 
antibiotic therapy; b) use of chlorhexidine mouthwash; c) 
local application of cold pads; d) use of steroid anti-inflam-
matory therapy if necessary; d) application of chlorhexidine 
gel after the first week; e) impeccable oral hygiene; f) no 
smoking; g) avoid loading the regenerated zone.
Graft infection is manifested by pain and inflammation and 
is usually accompanied by fistulas. This normally leads to 
expulsion of the material. Treatment consists of removing 
the graft material and careful debridement of  the zone 
to ensure good vascularisation and an area free of  any 
remainders of the graft material. Systemic antibiotics are 
always given.
PERI-IMPLANT INFECTION
It is essential to study and understand the gum-implant in-
terface in order to understand peri-implant physiopathology, 
because the soft tissues that surround implants have a very 
similar structure and composition to periodontal tissue. 
Supracrestal soft tissue that surrounds implants is called 
peri-implant mucosa and it forms a structure called peri-
implant surcus around the implant, similar to the gingival 
surcus. This tissue is covered with surcus epithelium and 
adherence epithelium on its internal surface, and oral 
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epithelium on its external surface that may be keratinised 
epithelium or simple alveolar mucosa. Amongst the cells 
nearest the root of the adherence epithelium and alveolar 
bone is the connective tissue zone that also comes into di-
rect contact with the implant surface. This is called lamina 
propria.
This anatomy determines a series of characteristics such as 
peri-implant probing, because the probe penetrates further 
in tissues surrounding the implants than in the periodontal 
surcus, also causing compression and lateral movement of 
peri-implant mucosa (32). This means that bleeding during 
probing is not a good indicator of peri-implant mucosa 
inflammation when pressure greater than 0.2 N/cm is used 
because it causes sideways dislocation of the mucosa (33, 
34).
The microbiology of peri-implant infection.
Mouth microbiology determines peri-implant microbiology: 
colonisation of implants is similar to the periodontal surcus 
following dental eruption (35) and therefore if  there is no 
pathological alteration, bacterial flora is similar to that 
of healthy periodontium (36, 37). When the implant is in 
function, in the event of pathological or para-axial loading 
leading to occlusal overloading or osseointegration loss due 
microfractured bone, this can cause apical migration of the 
epithelium that favours infection in the zone (38-41).
Periodontal and peri-implant diseases are multifactor pa-
thologies that have major bacterial aetiology (42). Strains 
associated with the onset and development of periodontal 
disease have also been identified in peri-implant tissue 
suffering peri-implantitis (43, 44). The main pathogens 
involved in peri-implantitis are gram-negative anaerobic 
bacteria, with an increased percentage of  motile rods, 
fusiform and spirochete bacilli (45-47). The most frequent 
ones are Prevotella intermedia, Fusobacterium nucleatum, 
Porphyromonas gingivalis, Capnocytophaga  and Campy-
lobacter rectus.
It is uncommon to find Actinobacillus actinomyceten-
comitans in peri-implantitis, and it appears to be more 
associated with Periodontal Disease. The presence of 
Porphyromonas gingivalis appears to indicate previous 
peri-implantitis or peri-implant mucositis (48). The presence 
of Porphyromonas gingivalis, Actinobacillus Actinomyce-
tencomitans or  Prevotella Intermedia in the peri-implant 
pocket indicates a higher risk of insertion loss during later 
phases (49, 50), and therefore patients who are partially 
edentulous are at a higher risk of infection than completely 
edentulous patients (5).
Clinical presentation of peri-implant diseases
A) Peri-implant mucositis 
This is a reversible inflammatory reaction in the soft tis-
sues that surround an implant in function. Clinically it is 
characterised by:
• Presence of bacterial plaque and calculus.
• Oedema, redness and mucosal hyperplasia.
• Bleeding affecting mucosal sealing on probing. 
• Exudate or pus formation on occasions (gingival mi-
croabscess).
• Radiological absence of bone reabsorption.
B) Peri-implant osteitis (Peri-implantitis)
This is an irreversible inflammatory reaction in the soft and 
hard tissues that surround an implant in function, because 
natural bone loss occurs if  no treatment is given. It has more 
floral clinical symptoms because in the initial phase it may 
present the same signs as peri-implant mucositis, but these 
are later accompanied by the symptoms of bone loss itself. 
The most common signs are:
• Presence of bacterial plaque and calculus.
• Oedema and redness of peripheral tissues. 
• Mucosal hyperplasia in zones with a lack of keratinised 
gingiva. 
• Increased probe depth. The level of  probe reaches the 
apex. 
• Bleeding and slight pus formation after probing and/or 
palpation.
• Vertical bone destruction in relation to peri-implant 
pocket.
• Radiological presence of bone reabsorption.
• Implant mobility.
• Pain is not very common, but is sometimes present.
A continuously moving implant and peri-implant radiolu-
cency indicate that the disease is reaching its final outcome, 
characterised by total loss of the bone-implant interface. 
Radiological examination is very important because al-
though X-rays only show bone on mesial and distal implant 
surfaces, the bone defects have a circular or funnel-shaped 
form and therefore are larger than those observed on an X-
ray. (51) Therefore two types of defects can be observed that 
will provide guidance to the aetiology, clinical development 
and prognosis of the case. 
• Horizontal defects: These develop slowly. They tend to 
have a more favourable prognosis because they are often 
associated with soft tissue recession. The angle that forms 
with the implant surface is greater than 60 degrees. 
• Vertical defects: These develop more quickly. They cause 
pockets with epithelial growth inside, and purulent infectio-
ns when probe depth is greater than 5 mm. The angle that 
forms with the implant surface is less than 60 degrees. 
Jovanovic and Spiekermann’s classification of peri-implan-
titis (1995) (52-53)
Peri-implantitis class 1: minimum horizontal bone destruc-
tion with slight peri-implant bone loss
Peri-implantitis class 2: moderate bone destruction with 
solitary vertical loss 
Peri-implantitis class 3: moderate or intense horizontal bone 
destruction with extensive circumferential bone lysis
Peri-implantitis class 4: intense horizontal bone destruction 
with extensive circumferential bone lysis and loss of lingual 
or vestibular bone wall
- Treatment
A) Treatment of implant mucositis
Treatment is principally focused on controlling bacterial 
plaque, although other surgical treatments may be perfor-
med to eliminate the hyperplasia of surrounding soft tissue 
as well as to graft keratinised gingiva, if  necessary. 
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Thus, treatment consists of several phases:
1. Professional peri-implant hygiene 
• Mechanical elimination of bacterial plaque (Vector- Durr) 
(54). 
• Irrigation of the surcus-pocket with 0.12% chlorhexidine 
(55).
• Removal and disinfection of the prosthesis and pillars. 
• Modification of unhygienic prosthesis designs.
• Sometimes a partial-thickness flap is performed to irrigate 
with sterile physiological saline, followed by the application 
of a tetracycline cream. 
 • LASER treatment with 1.5-2W diodes in refractory cases 
(56, 57).
2. Personal peri-implant hygiene
• Chemical plaque control with 0.12% chlorhexidine 12 
hourly. 
3. Local and systemic antibiotics
4. Regular professional control
B) Treatment of peri-implantitis
The fundamental requirement in successful peri-implantitis 
treatment, with or without the use of bone regeneration 
protocols, is to decontaminate the implant surface, removing 
bacteria and toxins.
Peri-implantitis treatment must be based on the stabilisation 
of progressive bone loss, and in special cases, to retrieve lost 
bone with regenerative treatment. 
The treatment can be divided into two phases: 
Phase 1: Initial conservation treatment






• Local application of tetracycline (58)  
B.2. Systemic
• Antibiotic therapy
C. Diode laser: 1 W for 20 seconds (59) 
Phase 2: Regenerative treatment
Treatment of soft tissues.
A crestal incision is scalloped around the implant neck to 
eliminate the internal epithelium and granulation tissue 
from the pocket. A mucoperiostic flap is lifted to expose 
the implant, and bone tissue and granulation tissue is eli-
minated from the bone defect with a metal curette without 
touching the implant. A cold sterile physiological saline 
solution is irrigated throughout the procedure to prevent 
bone dehydration.
Treatment of the implant surface.
First, the implant surface is decontaminated with successive 
topical applications of citric acid, tetracycline, chlorhexidine 
and sterile physiological saline. 
In the thread zone of the implant that will be exposed, an im-
plantoplasty is performed to attain a smooth, polished surface 
that will facilitate maintaining healthy peri-implant tissue.
 Finally, the surgical field is then irrigated with 0.2% chlor-
hexidine and sterile physiological saline.
Therapeutic guidelines, according to the degree of  peri-
implantitis 
Peri-implantitis class 1
Surgical reduction of pocket depth, thinning of mucosal 
flaps and apical repositioning of flaps at a bone edge level, 
using the corresponding suture technique.
The implant surface is clean and decontaminated. Implanto-
plasty is only performed if  threads are exposed.
Peri-implantitis class 2
Similar to class 1, but repositioning is performed more api-
cally, leaving more implant surface exposed, thus requiring 
an implantoplasty.
If  local vertical reabsorption has three or more walls, this 
bone defect is restored using classical GTR techniques. In 
cases where the defect involves one or two walls, osteoplasty 
or bone levelling is performed to favour soft tissue reposi-
tioning, to fulfil self-cleaning criteria.
Peri-implantitis class 3 and 4
In peri-implantitis class 3 and 4, the presence of vertical 
defects almost always permits the use of GTR techniques.
The following combinations can be employed, the exact 
choice depends on intra-operative findings. 
• Osteoplasty + implantoplasty + apical repositioning of 
the flap.
• Closed GTR + graft + coronal repositioning of the flap.
• Semiopen or transgingival GTR + implantoplasty + apical 
repositioning of the flap.
Antibiotic therapy in peri-implant diseases
One classical question that many authors have asked is 
whether the use of antibiotics is indicated in peri-implant 
disease. Back in 1985, Bascones (60) suggested that appro-
priate antibiotic therapy in PD has many benefits: it reduces 
the need for surgery, improves the patient’s clinical situa-
tion, and increases the success rate of graft and reinsertion 
techniques.
Since the early 90’s, experimental studies have reported on 
peri-implantitis lesions in animals that are resolved with 
antibiotic therapy (61, 62); finally, in a study by Gutiérrez 
Pérez et al. in 2003 (42) it was concluded that “treatment 
strategies in PD and peri-implant disease should be focused 
on the rational use of potent antimicrobial therapy”. Gar-
cía Calderón’s study (46) demonstrated the importance of 
giving systemic antibiotic therapy if  the peri-implant pocket 
is greater than 5 mm, because local antiseptics cannot re-
ach the bottom of the pocket. Therefore, the only possible 
answer to the question “Should antibiotics be used in peri-
implant infections?” is “yes”. 
Choice of antibiotic
The association amoxicillin-clavulanic acid is the treatment 
of choice in peri-implant disease because of the sensitivity 
of the germs involved and the low rate of resistant strains. 
Clindamycin and metronidazole are also indicated, but they 
are less effective against residual streptococcus and Acti-
nomyces , and since they grow after R and A techniques are 
used, these antibiotics should be considered as second line 
treatment. High-dose amoxicillin-clavulanic acid should be 
used due to the increased resistance of germs (42).
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ANTIBIOTIC THERAPY AND ANTIBIOTIC PRO-
PHYLAXIS IN IMPLANTOLOGY
One of  the most controversial issues in implantology is 
whether to use antibiotics preventively when performing 
an implant placement surgical procedure.
Antibiotic prophylaxis is understood as pre- or peri-opera-
tive administration of an antibiotic agent to prevent a local 
and/or systemic infectious complication and its correspon-
ding clinical consequences. The aim is therefore to prevent 
the onset of infection in the surgical wound by achieving 
an antibiotic concentration in the blood that will prevent 
bacterial proliferation and dissemination (62).
There are two fundamental factors that must be considered 
in odonto-stomatology and oral surgery: 
A) The invasive nature of the procedure: traditionally, two 
types of procedures have been described:
•  Invasive oral-dental procedures
•  Non-invasive oral-dental procedures
Invasive procedures are defined as procedures in which 
ruptured biological membranes might encourage bacterial 
dissemination throughout the body. High-risk invasive 











Endodontic surgery and apicectomy
Shaping procedures including bleeding
Pre-prosthetic surgery 
Orthognatic surgery
Reduction of maxillary fractures
Salivary gland surgery
Maxillofacial oncology surgery
B) Patient risk profile: this second parameter classifies 
patients into three groups:
• Healthy patients
• Patients with a risk factor of local or systemic infection
• Patients with a risk factor of  local infection following 
bacteraemia
In the case of  the first group there is nothing of  note. 
However the following types of diseases would be included 
in the risk profile:
1. Inflammatory joint diseases: Rheumatoid arthritis, syste-
mic lupus erythmatosus. 
2. Immunosuppression due to disease, drugs, transplants 
and radiotherapy 
3. Diabetes mellitus type I 
4. Infectious endocarditis protocols: previous endocarditis, 
prosthetic valves, congenital heart disease, surgical derivatives, 
acquired valve disease, hypertrophic cardiomyopathy, mitral 
valve prolapse, sustained murmurs and Marfan syndrome 
5. Osteoarticular prosthetic protocols: Within 2 years of 




 8. Grafts (local factor) 
 9. Other uncontrolled associated pathologies (RENAL or 
hepatic impairment), and splenectomy patients. 
Therefore, antibiotic prophylaxis is recommended in at risk pa-
tients who are undergoing high-risk invasive procedures (62).
The use of antibiotic prophylaxis is not so clear in implan-
tology. In Exposito’s study (64), it was demonstrated that 
the rate of infectious complications was higher in the case 
of osteotomy and long surgical procedures. The infecting 
inoculum increases in proportion to the length of time of 
the surgical procedure.
Therefore the probability of infection around dental im-
plants fundamentally depends on how traumatic and how 
long the surgery is. It is believed that uncommon early 
implant loss is due to contamination during implant pla-
cement (65, 66).
There is little work in the literature that refers to the appli-
cation of pre-operative antibiotics, and results are varied. 
Binhamed (67) found that greater efficacy was not observed 
with the use of  a 7-day post-operative antibiotic course 
against a single intra-operative dose. Similarly, Gynther 
(68) did not find significant differences in success rate or in 
complications between two patient groups using penicillin 
V against placebo pre-operatively. However, Laskin’s study 
(69) demonstrated a lower failure rate in patients given pre-
operative antibiotics. 
Finally, the 2003 Cochrane review (70), concluded that there 
is no evidence either to be able to recommend or to advise 
against the use of  antibiotics to prevent dental implant 
complications and failure, due to the absence of randomised, 
controlled clinical trials. 
In view of all this, should antibiotic prophylaxis be used in 
implantology? In our opinion, there are two situations in 
which it should be used, always under the same guidelines 
that apply in odontology in general: 1) whenever a patient 
has a major systemic risk factor; 2) if  surgery is expected 
to be long and/or traumatic.
With regard to other cases, there are no clear criteria to 
recommend or advise against prophylaxis 
Antibiotic regimens for the treatment of  implantology 
infections.
According to the criteria established by Gutiérrez Pérez et 
al. (42), and in the Consensus Document for the treatment 
and prophylaxis of infections in odonto-stomatology and 






2.- Spiramycin and Metronidazole
3.- Clarithromycin
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